Possible association between Budd‐Chiari syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia
暂无分享,去创建一个
K. Altundag | E. Kansu | M. Kurt | İ. Güllü | A. Shorbagi | Tamer Elkıran | K. Altundağ
[1] A. Lichtin,et al. Acute leukemia with a very high leukocyte count : Confronting a medical emergency , 2004 .
[2] P. Kamath,et al. The Budd-Chiari syndrome. , 2004, The New England journal of medicine.
[3] E. Estey,et al. Mylotarg™ (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation , 2001, Cancer.
[4] X. H. Chen,et al. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] E. Favaloro. Differential expression of surface antigens on activated endothelium , 1993, Immunology and cell biology.
[6] A. Duerinckx,et al. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. , 1993, AJR. American journal of roentgenology.
[7] E. van Marck,et al. The Budd-Chiari syndrome caused by a zygomycete. A new pathogenesis of hepatic vein thrombosis. , 1989, Archives of pathology & laboratory medicine.
[8] J. Riccio,et al. Hepatic vein thrombosis (Budd-Chiari syndrome) in the microgranular variant of acute promyelocytic leukemia. , 1989, American journal of clinical pathology.
[9] R. Chillar,et al. Case report: hepatic vein thrombosis (acute Budd-Chiari syndrome) in acute leukemia. , 1981, The American journal of the medical sciences.
[10] R. Young. The Budd-Chiari syndrome caused by Aspergillus; two patients with vascular invasion of the hepatic veins. , 1969, Archives of internal medicine.